Key result
A comprehensive strategy of pharmacological cardioprotection and optimized anesthetic support might decrease the incidence of severe cardiac complications and mortality in noncardiac surgery.
Why the study?
Does pharmacological cardioprotection and optimized anesthetic support reduce perioperative cardiac complications in high cardiac risk patients undergoing noncardiac surgery?
Does pharmacological cardioprotection and optimized anesthetic support reduce perioperative cardiac complications in high cardiac risk patients undergoing noncardiac surgery?
A comprehensive strategy including pharmacological cardioprotection and optimized anesthetic support may reduce severe cardiac complications and mortality in high-risk patients undergoing noncardiac surgery.
May warrant consideration in high-risk noncardiac surgery; leaves open the need for confirmatory RCTs.
The second part of the overview presents and analyzes the current data on the methods of adjuvant pharmacological cardioprotection and possibilities of optimizing the anesthetic support and perioperative monitoring in high cardiac risk patients. Amendments made in international guidelines for the last 2–3 years on the basis of conclusive studies and meta-analyses have been examined. Cardioprotection mechanisms and information about its implementation in real clinical practice have been analysed. It has been shown that by no means all drugs under discussion can be widely used for prophytlactic purposes. Contemporary evidencebased recommendations concerning the optimization of anesthetic support and perioperative monitoring are given. A conclusion has been made that practical implementation of a comprehensive strategy aimed at reduction of the risk of cardiac complications might ensure decrease of both the incidence of severe cardiac complications and mortality due to them.
No takes yet. Share an insight, caveat, or question.
Ia et al. (2019) conducted a review in High cardiac risk patients undergoing noncardiac surgery. Pharmacological cardioprotection and optimization of anesthetic support was evaluated. A comprehensive strategy of pharmacological cardioprotection and optimized anesthetic support might decrease the incidence of severe cardiac complications and mortality in noncardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: